News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
835,534 Results
Type
Article (85808)
Company Profile (755)
Press Release (748971)
Section
Business (232346)
Career Advice (4115)
Deals (39669)
Drug Delivery (122)
Drug Development (90752)
Employer Resources (194)
FDA (18006)
Job Trends (17283)
News (395783)
Policy (39639)
Tag
Academia (2975)
Alliances (56609)
Alzheimer's disease (1385)
Approvals (17937)
Artificial intelligence (186)
Bankruptcy (396)
Best Places to Work (12585)
Biotechnology (519)
Breast cancer (208)
Cancer (1554)
Cardiovascular disease (135)
Career advice (3519)
Cell therapy (341)
Clinical research (72172)
Collaboration (570)
Compensation (305)
COVID-19 (2817)
C-suite (134)
Data (1471)
Diabetes (202)
Diagnostics (6725)
Earnings (94880)
Employer resources (167)
Events (127682)
Executive appointments (466)
FDA (18781)
Funding (517)
Gene therapy (239)
GLP-1 (735)
Government (5059)
Healthcare (20795)
Infectious disease (2921)
Inflammatory bowel disease (127)
Interviews (808)
IPO (17671)
Job creations (5180)
Job search strategy (2856)
Layoffs (501)
Legal (10056)
Lung cancer (234)
Manufacturing (245)
Medical device (14466)
Medtech (14471)
Mergers & acquisitions (22199)
Metabolic disorders (556)
Neuroscience (1763)
NextGen: Class of 2025 (7670)
Non-profit (5071)
Northern California (1847)
Obesity (316)
Opinion (252)
Patents (137)
People (64490)
Pharmaceutical (152)
Phase I (22244)
Phase II (31338)
Phase III (23616)
Pipeline (567)
Postmarket research (3550)
Preclinical (10020)
Radiopharmaceuticals (261)
Rare diseases (304)
Real estate (7375)
Regulatory (26197)
Research institute (2644)
Resumes & cover letters (649)
Southern California (1611)
Startups (4279)
United States (17329)
Vaccines (674)
Weight loss (247)
Date
Today (138)
Last 7 days (900)
Last 30 days (2143)
Last 365 days (37627)
2025 (1011)
2024 (38191)
2023 (42569)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (236)
Asia (49587)
Australia (8734)
California (4307)
Canada (1544)
China (361)
Colorado (196)
Connecticut (214)
Europe (113545)
Florida (592)
Georgia (152)
Illinois (488)
Indiana (253)
Maryland (726)
Massachusetts (3440)
Michigan (204)
Minnesota (333)
New Jersey (1218)
New York (1201)
North Carolina (911)
Northern California (1847)
Ohio (161)
Pennsylvania (1004)
South America (1649)
Southern California (1611)
Texas (637)
Utah (126)
Washington State (464)
There are 835,534 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Defence to Connect with Industry Leaders and Potential Partners During the JP Morgan Healthcare Conference in San Francisco. Plans to Expand the Next Generation of Radio-Immuno Conjugates in 2025
January 10, 2025
·
4 min read
Press Releases
Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
January 10, 2025
·
8 min read
Press Releases
GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents
January 10, 2025
·
7 min read
Press Releases
Neogen Announces Preliminary¹ Second-Quarter 2025 Results
January 10, 2025
·
19 min read
Press Releases
AKTIS ONCOLOGY TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
January 10, 2025
·
1 min read
Press Releases
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis
January 10, 2025
·
8 min read
Press Releases
LAVA Doses First Patient in Phase 1 LAVA-1266 Study in Hematological Cancers
January 10, 2025
·
6 min read
Press Releases
NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers
January 10, 2025
·
3 min read
Press Releases
ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease
January 10, 2025
·
8 min read
Press Releases
Totus Medicines Announces Successful Completion of a Phase 1 Dose-Escalation Study and Initiation of an Expansion Trial Evaluating TOS-358, a Covalent PI3Ka Selective Therapy for the Treatment of Select Solid Tumors and Appoints Zelanna Goldberg as Chief Medical Officer
January 10, 2025
·
3 min read
1 of 83,554
Next